Das Zentrum
Multiple Sklerose Zentrum Dresden
Patienteninformation
Kontaktinformation
Behandlungsteam
Studienteam
Neuropsychologie
Mobilitätszentrum
Das Mobilitätszentrum
Ganganalyse
Sprunganalyse
DIERS
EMIQ
Forschungsprojekte
Neuroimmunologisches Labor
Das NIL
Neurofilament-Leichtketten Analyse
Autonomes & Neuroendokrinologisches Funktionslabor
Das ANF
Untersuchungsmethoden
MS Living Lab
Management & Science
Team Management & Science
Projekte
eHealth & Analytics
MSDS 3D
MSDS Klinik & Praxis
MS-HRS
MTRS
MS Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
Deutsch
Deutsch
English (UK)
Label-free electrical impedance spectroscopy based sensor-in-a-tube for single cells analysis
NIL
Jahr
Publikationsjahr
2019
Autoren
Autorenliste der Publikation
Egunov AI, Medina-Sánchez M, Karnaushenko DD, Kretschmann N, Akgün K, Ziemssen T, Karnaushenko D, Schmidt OG.
Verlag
Publisher-Information
23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2019, pp. 1360 - 1361.
Link
Zur Publikation (externer Server)
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094953454&partnerID=40&md5=c90caa8615acc1aa1269451291eb100b
Tags
Forschungsthemen
Neuroimmunologie
Andere
Andere
NIL
2019
Neurological complications in oncology and their monitoring and management in clinical practice: a narrative review
Other
Jahr
2024
Serum neurofilament light chain as a sensitive biomarker for neuromonitoring during extracorporeal membrane oxygenation
NIL
Jahr
2024
Raman Spectroscopy of Optically Trapped Living Human T Cell Subsets and Monocytes
NIL
Jahr
2024
COVID-19 and multiple sclerosis: challenges and lessons for patient care
Multiple Sclerosis
Jahr
2024
Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 2023, 11, 1374
NIL
Jahr
2024